Page last updated: 2024-09-05

campesterol and Cardiovascular Diseases

campesterol has been researched along with Cardiovascular Diseases in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's9 (75.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Baumgartner, S; Joris, PJ; Kleinloog, JPD; Mashnafi, S; Mensink, RP; Plat, J1
Lagadic-Gossmann, D; Le Ferrec, E; Le Goff, M; Mayer, C; Mimouni, V; Schoefs, B; Ulmann, L1
Baumgartner, S; Mashnafi, S; Mensink, RP; Plat, J1
Aguirre, AC; Amaral, JB; Barbosa, SP; Bianco, HT; Fonseca, FA; França, CN; Izar, MC; Lins, LC; Matos, LN; Santana, JM1
Alegría, A; Barberá, R; Blanco-Navarro, I; Donoso-Navarro, E; Garcia-Llatas, G; Garcia-López, FJ; Granado-Lorencio, F; Lagarda, MJ; Pérez-Sacristán, B; Sánchez-Siles, LM; Silvestre-Mardomingo, RA1
Berendschot, TT; Kelly, ER; Kijlstra, A; Lütjohann, D; Plat, J; van der Made, SM1
Gylling, H; Hallikainen, M; Miettinen, TA; Raitakari, OT; Viikari, J1
Basora, J; Bulló, M; Cofán, M; Corella, D; Escurriol, V; Estruch, R; Martínez-González, MA; Ros, E; Ruiz-Gutiérrez, V; Salas-Salvadó, J; Serra, M; Zazpe, I1
Boehm, BO; Fauler, G; Hoffmann, MM; Lütjohann, D; März, W; Silbernagel, G; Winkelmann, BR1
Ishibashi, S; Kotani, K; Miyamoto, M; Nagasaka, S; Okada, K; Osuga, J; Yagyu, H1
Bañuls, C; Bellod, L; Hernández-Mijares, A; Jover, A; Lagarda, MJ; Martínez-Triguero, ML; Rocha, M; Solá, E; Víctor, VM1
Bruckert, E; Carmena, R; Chapman, MJ; De Backer, G; Deanfield, J; Descamps, OS; Dias, KC; Genser, B; März, W; Rietzschel, ER; Silbernagel, G1

Reviews

3 review(s) available for campesterol and Cardiovascular Diseases

ArticleYear
Microalgal carotenoids and phytosterols regulate biochemical mechanisms involved in human health and disease prevention.
    Biochimie, 2019, Volume: 167

    Topics: Apoptosis; Carbohydrate Metabolism; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Humans; Lipid Metabolism; Metabolic Diseases; Microalgae; Neoplasms; Phytosterols; Signal Transduction; Sitosterols; Xanthophylls

2019
Non-Cholesterol Sterol Concentrations as Biomarkers for Cholesterol Absorption and Synthesis in Different Metabolic Disorders: A Systematic Review.
    Nutrients, 2019, Jan-09, Volume: 11, Issue:1

    Topics: Biomarkers; Cardiovascular Diseases; Cholesterol; Desmosterol; Diabetes Mellitus; Humans; Intestinal Absorption; Intestinal Diseases; Kidney Diseases; Liver Diseases; Metabolic Diseases; Obesity; Overweight; Phytosterols; Sitosterols; Sterols

2019
Plant sterols and cardiovascular disease: a systematic review and meta-analysis.
    European heart journal, 2012, Volume: 33, Issue:4

    Topics: Cardiovascular Diseases; Cholesterol; Diet; Epidemiologic Methods; Humans; Phytosterols; Publication Bias; Risk Factors; Sitosterols

2012

Trials

7 trial(s) available for campesterol and Cardiovascular Diseases

ArticleYear
Effects of an 8-week aerobic exercise program on plasma markers for cholesterol absorption and synthesis in older overweight and obese men.
    Lipids in health and disease, 2021, Sep-21, Volume: 20, Issue:1

    Topics: Aged; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Exercise; Exercise Therapy; Humans; Life Style; Male; Middle Aged; Obesity; Overweight; Phytosterols; Sterols; Surveys and Questionnaires

2021
Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.
    Life sciences, 2013, May-02, Volume: 92, Issue:14-16

    Topics: Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Desmosterol; Ezetimibe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Phytosterols; Prospective Studies; Pyrroles; Risk Factors; Sitosterols; Statistics, Nonparametric

2013
Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: a randomized crossover trial.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014, Volume: 24, Issue:10

    Topics: Administration, Oral; Aged; Bone and Bones; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Cryptoxanthins; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Hypercholesterolemia; Middle Aged; Phytosterols; Postmenopause; Risk Factors; Sitosterols; Treatment Outcome; Triglycerides

2014
Consuming a buttermilk drink containing lutein-enriched egg yolk daily for 1 year increased plasma lutein but did not affect serum lipid or lipoprotein concentrations in adults with early signs of age-related macular degeneration.
    The Journal of nutrition, 2014, Volume: 144, Issue:9

    Topics: Aged; Beverages; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cultured Milk Products; Diet; Dietary Supplements; Disease Progression; Egg Yolk; Female; Humans; Intestinal Absorption; Lutein; Macular Degeneration; Male; Middle Aged; Phytosterols; Time Factors

2014
Serum sterol responses to increasing plant sterol intake from natural foods in the Mediterranean diet.
    European journal of nutrition, 2009, Volume: 48, Issue:6

    Topics: Aged; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Diet, Fat-Restricted; Diet, Mediterranean; Dietary Fats; Energy Intake; Female; Food; Food Analysis; Humans; Isomerism; Lipids; Male; Middle Aged; Nuts; Olea; Patient Education as Topic; Phytosterols; Plants, Edible; Risk Factors; Sitosterols; Statistics as Topic; Surveys and Questionnaires

2009
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
    Endocrine journal, 2010, Volume: 57, Issue:10

    Topics: Aged; Azetidines; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholestanol; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Phytosterols; Sitosterols

2010
Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome.
    Clinical nutrition (Edinburgh, Scotland), 2011, Volume: 30, Issue:5

    Topics: Adult; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol; Cholesterol, Dietary; Dietary Supplements; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Intestinal Absorption; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Phytosterols; Risk Factors; Severity of Illness Index; Sitosterols; Spain

2011

Other Studies

2 other study(ies) available for campesterol and Cardiovascular Diseases

ArticleYear
Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2009, Volume: 19, Issue:8

    Topics: Adolescent; Adult; Age Factors; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Cholestanol; Cholesterol; Chromatography, Gas; Chromatography, Liquid; Desmosterol; Female; Finland; Follow-Up Studies; Humans; Intestinal Absorption; Male; Phytosterols; Population Surveillance; Registries; Risk Factors; Sitosterols; Time Factors

2009
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality.
    Journal of lipid research, 2010, Volume: 51, Issue:8

    Topics: Absorption; Cardiovascular Diseases; Cholestanol; Cholesterol; Humans; Male; Middle Aged; Phytosterols; Prognosis; Risk; Sitosterols

2010